SIRION-BIOTECH

SIRION Biotech possesses one of the world's most comprehensive viral vector technology platforms addressing all three major vector types - Lentivirus, Adenovirus and AAV. Services range from custom virus design to virus vector productions and cell modelling projects, including multicistronic expression systems and superior gene knockdown strategies (RNAiONE™). With its many advanced in-house developments SIRION Biotech is able to present new solutions for viral vector systems in modern research, narrowing the gap between in vitro models and in vivo applications... SIRION Biotech is committed to improving clinical use of viral vectors, ultimately for the benefit of patients. The spirit of quality and awareness of the immediate impact of everyone's work on clinical research and therapy performance is communicated through our employees. We share our values by word and through action, like the royalty-free access program to SIRION's LentiBOOST® technology to research hospitals... SIRION..

Also known as: Sirion-Biotech GmbH

Registration numbers: HRB161010 (W)

VAT numbers: DE246657785

Primary location: Graefelfing Germany